359 related articles for article (PubMed ID: 18706834)
1. Matrix metalloproteinase-9/tissue inhibitors of metalloproteinase-1 expression and atrial structural remodeling in a dog model of atrial fibrillation: inhibition with angiotensin-converting enzyme.
Zhang W; Zhong M; Yang GR; Li JP; Guo C; Wang Z; Zhang Y
Cardiovasc Pathol; 2008; 17(6):399-409. PubMed ID: 18706834
[TBL] [Abstract][Full Text] [Related]
2. Matrix metalloproteinases and atrial remodeling in patients with mitral valve disease and atrial fibrillation.
Anné W; Willems R; Roskams T; Sergeant P; Herijgers P; Holemans P; Ector H; Heidbüchel H
Cardiovasc Res; 2005 Sep; 67(4):655-66. PubMed ID: 15913581
[TBL] [Abstract][Full Text] [Related]
3. [Effects of matrix metalloproteinase-9 and tissue inhibitor-1 of metalloproteinase expression on atrial structural remodeling during chronic atrial fibrillation].
Zhu H; Zhang W; Guo CH; Zhang G; Zhang WD; Zhong M; Yang GR; Ge ZM; Zhang Y
Zhonghua Yi Xue Za Zhi; 2005 Jan; 85(1):45-8. PubMed ID: 15808077
[TBL] [Abstract][Full Text] [Related]
4. Upregulation of matrix metalloproteinase-9 and tissue inhibitors of metalloproteinases in rapid atrial pacing-induced atrial fibrillation.
Chen CL; Huang SK; Lin JL; Lai LP; Lai SC; Liu CW; Chen WC; Wen CH; Lin CS
J Mol Cell Cardiol; 2008 Dec; 45(6):742-53. PubMed ID: 18692064
[TBL] [Abstract][Full Text] [Related]
5. Matrix metalloproteinase-9 contributes to human atrial remodeling during atrial fibrillation.
Nakano Y; Niida S; Dote K; Takenaka S; Hirao H; Miura F; Ishida M; Shingu T; Sueda T; Yoshizumi M; Chayama K
J Am Coll Cardiol; 2004 Mar; 43(5):818-25. PubMed ID: 14998623
[TBL] [Abstract][Full Text] [Related]
6. [Effects of angiotensin converting enzyme inhibitor on the expression of angiotensin converting enzyme 2 in atrium of patients with atrial fibrillation].
Hu XS; Xie XD; Wang XX; Zeng CL; Ni YM; Yu GW; Chen JZ
Zhonghua Xin Xue Guan Bing Za Zhi; 2007 Jul; 35(7):625-8. PubMed ID: 17961427
[TBL] [Abstract][Full Text] [Related]
7. Expression and response to angiotensin-converting enzyme inhibition of matrix metalloproteinases 2 and 9 in renal glomerular damage in young transgenic rats with renin-dependent hypertension.
Bolbrinker J; Markovic S; Wehland M; Melenhorst WB; van Goor H; Kreutz R
J Pharmacol Exp Ther; 2006 Jan; 316(1):8-16. PubMed ID: 16166267
[TBL] [Abstract][Full Text] [Related]
8. Angiotensin II receptor type 1 is upregulated in atrial tissue of patients with rheumatic valvular disease with atrial fibrillation.
Cong H; Li X; Ma L; Jiang H; Mao Y; Xu M
J Thorac Cardiovasc Surg; 2010 Aug; 140(2):298-304. PubMed ID: 20080265
[TBL] [Abstract][Full Text] [Related]
9. Differential gene expression during atrial structural remodeling in human left and right atrial appendages in atrial fibrillation.
Zhu H; Zhang W; Zhong M; Zhang G; Zhang Y
Acta Biochim Biophys Sin (Shanghai); 2011 Jul; 43(7):535-41. PubMed ID: 21659381
[TBL] [Abstract][Full Text] [Related]
10. The angiotensin-calcineurin-NFAT pathway mediates stretch-induced up-regulation of matrix metalloproteinases-2/-9 in atrial myocytes.
Saygili E; Rana OR; Meyer C; Gemein C; Andrzejewski MG; Ludwig A; Weber C; Schotten U; Krüttgen A; Weis J; Schwinger RH; Mischke K; Rassaf T; Kelm M; Schauerte P
Basic Res Cardiol; 2009 Jul; 104(4):435-48. PubMed ID: 19148693
[TBL] [Abstract][Full Text] [Related]
11. [Involvement of matrix metalloproteinases in the regulation of myocardial extracellular matrix in patients with congestive heart failure].
Yang YJ; Zhang X; Zhu WL; Huang Y
Zhonghua Yi Xue Za Zhi; 2006 Jun; 86(24):1693-6. PubMed ID: 16854324
[TBL] [Abstract][Full Text] [Related]
12. Downregulation of angiotensin converting enzyme II is associated with pacing-induced sustained atrial fibrillation.
Pan CH; Lin JL; Lai LP; Chen CL; Stephen Huang SK; Lin CS
FEBS Lett; 2007 Feb; 581(3):526-34. PubMed ID: 17254576
[TBL] [Abstract][Full Text] [Related]
13. ACE-inhibitor treatment attenuates atrial structural remodeling in patients with lone chronic atrial fibrillation.
Boldt A; Scholl A; Garbade J; Resetar ME; Mohr FW; Gummert JF; Dhein S
Basic Res Cardiol; 2006 May; 101(3):261-7. PubMed ID: 16382287
[TBL] [Abstract][Full Text] [Related]
14. [The relation between angiotensin II receptors 1 and 2, and CYP11B2 and atrial structural remodeling in patients with atrial fibrillation].
Wu YQ; Wang XD; Fang H; Wang YL; Zhang YC; Su LJ
Zhonghua Yi Xue Za Zhi; 2007 Aug; 87(32):2281-4. PubMed ID: 18001553
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of matrix metalloproteinase activity and growth of gastric adenocarcinoma cells by an angiotensin converting enzyme inhibitor in in vitro and murine models.
Williams RN; Parsons SL; Morris TM; Rowlands BJ; Watson SA
Eur J Surg Oncol; 2005 Nov; 31(9):1042-50. PubMed ID: 15993560
[TBL] [Abstract][Full Text] [Related]
16. Matrix metalloproteinase inhibition attenuates atrial remodeling and vulnerability to atrial fibrillation in a canine model of heart failure.
Moe GW; Laurent G; Doumanovskaia L; Konig A; Hu X; Dorian P
J Card Fail; 2008 Nov; 14(9):768-76. PubMed ID: 18995182
[TBL] [Abstract][Full Text] [Related]
17. [Role of matrix metalloproteinase and tissue inhibitor of metalloproteinase in atrial structural remodeling in patients with atrial fibrillation].
Wang W; Wu PS; Yang XL
Nan Fang Yi Ke Da Xue Xue Bao; 2010 May; 30(5):1160-2. PubMed ID: 20501421
[TBL] [Abstract][Full Text] [Related]
18. Effects of amiodarone on electrical and structural remodeling induced in a canine rapid pacing-induced persistent atrial fibrillation model.
Ashikaga K; Kobayashi T; Kimura M; Owada S; Sasaki S; Iwasa A; Furukawa K; Motomura S; Okumura K
Eur J Pharmacol; 2006 Apr; 536(1-2):148-53. PubMed ID: 16556442
[TBL] [Abstract][Full Text] [Related]
19. Angiotensin II receptor blockade reduces tachycardia-induced atrial adhesion molecule expression.
Goette A; Bukowska A; Lendeckel U; Erxleben M; Hammwöhner M; Strugala D; Pfeiffenberger J; Röhl FW; Huth C; Ebert MP; Klein HU; Röcken C
Circulation; 2008 Feb; 117(6):732-42. PubMed ID: 18227384
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of matrix metalloproteinase-9 activity by lisinopril after myocardial infarction in hamsters.
Takai S; Yamamoto D; Jin D; Inagaki S; Yoshikawa K; Tanaka K; Miyazaki M
Eur J Pharmacol; 2007 Jul; 568(1-3):231-3. PubMed ID: 17512521
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
